References
- Bax A., Freeman R. Investigation of complex networks of spin-spin coupling by two-dimensional n.m.r. Journal of Magnetic Resonance 1981; 44: 542
- Daly J. W., Jerina D. M., Witkop B. Arene oxides and the NIH shift: the metabolism, toxicity and carcinogenicity of aromatic compounds. Experientia 1972; 28: 1129–1149
- Doddrell D. M., Pegg D. T., Bendall M. R. Distortionless enhancement of n.m.r. signals by polarisation transfer. Journal of Magnetic Resonance 1982; 48: 323–327
- Everett J. R., Jennings K., Woodnut G. 19F n.m.r. spectroscopy study of the metabolites of flucloxacillin in rat urine. Journal of Pharmacy and Pharmacology 1985; 37: 869–873
- Gabbay K. H. The sorbitol pathway and the complications of diabetes. New England Journal of Medicine 1973; 288: 831–836
- Johnson P., Rising P. A., Rising T. J. Liquid scintillation counting of biological samples using extended standardisation and automatic data processing. Liquid Scintillation Counting, M. A. Crook, P. Johnson, B. Scales. Heyden, London 1972; Vol. 2: 267–277
- Malet-Martino M. C., Martino R. The application of nuclear magnetic resonance spectroscopy to drug metabolism studies. Xenobiotica 1989; 19: 583–607
- Nicholson J. K., Wilson I. D. Solid-phase extraction chromatography and nuclear magnetic resonance spectrometry for the identification and isolation of drug metabolites in urine. Analytical Chemistry 1987; 59: 2830–2832
- Nicholson J. K., Wilson I. D. High resolution proton magnetic resonance spectroscopy of biological fluids. Progress in N.M.R. Spectroscopy 1989; 21: 449–501
- Park Y. H., Hudson J. E., Barker R. C., York B. M., Brazzell R. K. Metabolism of the aldose reductase inhibitor AL01567 in man. British Journal of Clinical Pharmacology 1991; 32: 221–227
- Park Y. H., Wooldridge C. B., Mattern J., Stoltz M. L., Brazzell R. K. Disposition of the aldose reductase inhibitor AL01576 in rats. Journal of Pharmaceutical Sciences 1988; 77: 110–115
- Preece N. E., Timbrell J. A. Use of n.m.r. spectroscopy in drug metabolism studies: recent advances. Progress in Drug Metabolism 1990; 12: 147–203
- Safe S., Jones D., Hutzinger O. Metabolism of 4,4′-dihalogenobiphenyls. Journal of the Chemical Society 1976; 357–359, Perkin I
- Sato S., Kador P. F. Inhibition of aldehyde reductase by aldose reductase inhibitors. Biochemical Pharmacology 1990; 40: 1033–1042
- Vialaneix J. P., Malet-Martino M. C., Hoffman J. S., Pris J., Martino R. Direct detection of new flucytosine metabolites in human biofluids by 19F nuclear magnetic resonance. Drug Metabolism and Disposition 1987; 5: 718–724
- Wade K. E., Troke J., Macdonald C. M., Wilson I. D., Nicholson J. K. 19F studies of the metabolism of trifluoro-methylaniline. Bioanalysis of Drugs and Metabolites, E. Reid, J. D. Robinson, I. D. Wilson. Plenum, London and New York 1988; 383–387